<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7287466\results\search\testTrace\results.xml">
  <result pre="high inflammatory state, and coagulation cascade abnormalities reported in ECoVs," exact="testing" post="for C-reactive protein, serum creatine kinase, and D-dimer level"/>
  <result pre="case reporting need be advanced, aiming at creation of the" exact="infection" post="control models and venture clinical trials for therapies advancements"/>
  <result pre="hospitalized pediatrics cases presenting with CNS and acute respiratory tract" exact="infection" post="(ARI), CoV infection observed in 12.02% of the cases"/>
  <result pre="presenting with CNS and acute respiratory tract infection (ARI), CoV" exact="infection" post="observed in 12.02% of the cases presenting with CNS"/>
  <result pre="followed by headache and vomiting [19]. It is apparent that" exact="infection" post="by the SARS virus not restricted to the lungs,"/>
  <result pre="8% with seizure presentation [23]. Neurological pathologies secondary to MERS" exact="treatment" post="abundantly observed [24]. Similar to SARS-CoV, the MERS-CoV infection"/>
  <result pre="MERS treatment abundantly observed [24]. Similar to SARS-CoV, the MERS-CoV" exact="infection" post="exhibits systemic complications, and CNS involvement appears to be"/>
  <result pre="years, concurrently, nearly 17% of the HCW reported with SARS-CoV" exact="infection" post="[31], [32]. In the most contemporary ECoV pandemic, the"/>
  <result pre="In the most contemporary ECoV pandemic, the COVID-19, notwithstanding meticulous" exact="quarantine" post="attempts globally, the rate of COVID-19 advances, with &amp;gt;4,000,000"/>
  <result pre="two days; further, neurologic symptoms emerging as an important differential" exact="diagnosis" post="for COVID-19 [15], [21]. Considering that, the neurologist must"/>
  <result pre="concentrating on neurological manifestation only. The clinical standards for SARS" exact="diagnosis" post="require the presence of a history of pyrexia, or"/>
  <result pre="of lung infiltrates compatible with pneumonia and non-existence of alternative" exact="diagnosis" post="that can thoroughly describe the disease [40]. The initial"/>
  <result pre="preceding ECoV infections noted. However, few cases with SARS-CoV-2 an" exact="infection" post="had striking upper respiratory tract signs and symptoms and"/>
  <result pre="that attain the case definition for suspected COVID-19 require a" exact="screening" post="priority for the SARS-CoV-2 with RT-PCR [48], [49]. 3.2"/>
  <result pre="lady, SE presented with reappearing seizures not responding to phenytoin" exact="treatment" post="and extended episodes up to 30Ã‚ min accompanied with"/>
  <result pre="toxicity (Ribavirin), acute renal failure (ARF), Acid-base changes, and CNS" exact="infection" post="obliged. In the inadequacy of contraindications, a lumbar puncture"/>
  <result pre="MRI revealed hyperintensities lesions. Further, there are reports on the" exact="diagnosis" post="confirmation by positive CSF RT-PCR rather than a nasopharyngeal"/>
  <result pre="explicated acute denervation. Of note, large doses of intravenous corticosteroid" exact="treatment" post="may generate acute steroid myopathy [57], [61]. Further, regarding"/>
  <result pre="postmortem skeletal muscle research based on 8 SARS cases, the" exact="diagnosis" post="of critical illness myopathy (CIM) was verified based on"/>
  <result pre="the nonexistence of myofiber atrophy in subjects with no steroid" exact="treatment" post="proposes the contribution of steroid as the essential agent"/>
  <result pre="the ICU contexts and propose notable morbidity and mortality rates;" exact="diagnosis" post="proposed when a critically ill case presents with limb"/>
  <result pre="symptoms without any comorbidities, ended up with ICU care, neurological" exact="testing" post="revealed symmetrical lower limb weakness, with intact sensations, mildly"/>
  <result pre="The COVID 19 Miller Fisher syndrome (MFS) symptoms preceded by" exact="infection" post="and presented with ageusia, bilateral abducent nerve palsy, areflexia,"/>
  <result pre="dosages may influence CIM. Hence, to limit CIM, avoiding corticosteroid" exact="treatment" post="is recommended [57], [79]. 5 Conclusion Unlike SARS and"/>
  <result pre="and MERS: recent insights into emerging coronavirusesNat Rev Microbiol148201652353427344959 18BergmannC.C.LaneT.E.StohlmanS.A.Coronavirus" exact="infection" post="of the central nervous system: host-virus stand-offNat Rev Microbiol42200612113216415928"/>
  <result pre="respiratory tract show distinct features in hospitalized childrenIntervirology59201616316928103598 20GuJ.GongE.ZhangB.ZhengJ.GaoZ.ZhongY.Multiple organ" exact="infection" post="and the pathogenesis of SARSJ ExpMed2022005415424 21KimJ.-E.HeoJ.-H.KimH.Neurological complications during"/>
  <result pre="infection and the pathogenesis of SARSJ ExpMed2022005415424 21KimJ.-E.HeoJ.-H.KimH.Neurological complications during" exact="treatment" post="of Middle East respiratory syndromeJ Clin Neurol133201722728748673 22ArabiY.M.HarthiA.HusseinJ.Severe neurologic"/>
  <result pre="23ChafekarAasiyahFieldingBurtramMERS-CoV: understanding the latest human coronavirus threatViruses102201893 24KimJ.E.HeoJ.H.KimH.O.SongS.H.ParkS.S.ParkT.H.Neurological complications during" exact="treatment" post="of middle east respiratory syndromeJ Clin Neurol13201722723328748673 25ChenN.ZhouM.DongX.Epidemiological and"/>
  <result pre="the Healthcare Infection Control Practices Advisory Committee, 2007 Guideline for" exact="isolation" post="precautions: preventing transmission of infectious agents in healthcare settings."/>
  <result pre="Syndrome CoronavirusJ Infect745201752152328189714 46HuangP.WangH.CaoZ.A rapid and specific assay for the" exact="detection" post="of MERS-CoVFront Microbiol92018110129896174 47Novel CoronavirusJapan(ex-China) https://www.who.int/csr/don/17-january-2020-novel-coronavirus-japan-ex-china/en/. 48Laboratory testing for"/>
  <result pre="for the detection of MERS-CoVFront Microbiol92018110129896174 47Novel CoronavirusJapan(ex-China) https://www.who.int/csr/don/17-january-2020-novel-coronavirus-japan-ex-china/en/. 48Laboratory" exact="testing" post="for 2019 novel coronavirus (2019-nCoV) in suspected human cases"/>
  <result pre="Jan 25, 2020). 49Global surveillance for COVID-19 caused by human" exact="infection" post="with COVID-19 virus Interim guidance 20 March 2020 https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical"/>
  <result pre="Stamford, Conn: Appleton &amp;amp; Lange, 2018. 51LauK.K.YuW.C.ChuC.M.LauS.T.ShengB.YuenK.Y.Possible central nervous system" exact="infection" post="by SARS coronavirusEmerg Infect Dis102200434234415030709 52SohalS.MansurM.COVID-19 presenting with seizuresIDCases202020e00782"/>
  <result pre="without respiratory failure in a young female patient with COVID-19" exact="infection" post="in Downtown Los Angeles, early April 2020 [published online"/>
  <result pre="with negative anti-ganglioside antibodiesBMC Res Notes52012295Published 2012 Jun 1422698187 75LuH.Drug" exact="treatment" post="options for the 2019-new coronavirus (2019-nCoV) [published online ahead"/>
  <result pre="recursive two-stage group sequential randomized controlled trialTrials212020831900204 78ChongY.P.SongJ.Y.SeoY.B.ChoiJ.P.ShinH.S.Rapid Response TeamAntiviral" exact="treatment" post="guidelines for Middle East respiratory syndromeInfect Chemother47201521222226483999 79SunL.Y.ChuX.L.Acute myopathy"/>
 </snippets>
</snippetsTree>
